- Business
- Maj Invest Global Sundhed (MAJGS.CO), a sub-fund of Investeringsforeningen Maj Invest, is an equity mutual fund that invests primarily in global healthcare and climate & environment sectors, with approximately two-thirds allocated to climate and environmental stocks such as renewable energy, solar panels, and green technologies (e.g., Sunnova Energy, Plug Power, Xylem Inc.), and one-third to healthcare companies focused on medical innovation, life sciences, pharmaceuticals, and wellness providers (e.g., UnitedHealth Group, Johnson & Johnson, Eli Lilly, Bavarian Nordic); the fund targets sustainable growth through companies improving access to health, well-being, and green transition technologies. Launched in 2008 as part of Maj Invest's mutual fund platform, it was originally named Maj Invest Miljø & Klima before rebranding to Global Sundhed in 2013, and most recently underwent a significant name change to Maj Invest Planet & People effective September 19, 2024, to better reflect its dual focus on planetary sustainability and human health investments; this renaming was accompanied by strategic updates aligning with the fund's ESG-oriented portfolio, which maintains a blend style with large-cap emphasis and a yield of around 24%. The fund, domiciled in Denmark with assets under management of approximately DKK 861 million (USD equivalent ~125 million), operates globally with top holdings including Novo Nordisk and international healthcare leaders, serving retail and institutional investors primarily in Denmark and Europe through NASDAQ OMX Copenhagen listings. Maj Invest, the parent group founded in 2005 and headquartered in Copenhagen, Denmark, manages the fund within its broader asset management division, which oversees listed equities, bonds, and sustainable strategies for institutional clients across Denmark, Europe, North America, and select emerging markets; recent group-level developments include new UCITS ETF launches in gold, silver, mining, and defense sectors in August 2025, as well as private equity partnerships like the January 2025 investment in energy-efficient heating solutions by Maj Invest Equity. In 2024, the fund featured portfolio adjustments such as reductions in Novo Nordisk and additions in climate-focused names, contributing to its performance amid sector volatility, with no major funding rounds or acquisitions directly tied to this sub-fund but benefiting from the group's overall AUM growth to over DKK 112 billion.